Agilon HealthAGL +0.69%74 PB Ratio is 9.88 as of Jun. 26, 2026, which is 69% above its 10-year median of 5.84. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.48 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Agilon Health ranks worse than 93.78% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Agilon Health's share price is $107.99. Agilon Health's Book Value per Share for the quarter that ended in Mar. 2026 was $10.93. Hence, Agilon Health's PB Ratio of today is 9.88.
Warning Sign:
Agilon Health Inc stock PB Ratio (=9.82) is close to 3-year high of 10.42.
The historical rank and industry rank for Agilon Health's PB Ratio or its related term are showing as below:
AGL'
s PB Ratio Range Over the Past 10 Years
Min: 0.78 Med: 5.84 Max: 13.13
Current: 9.88
During the past 7 years, Agilon Health's highest PB Ratio was 13.13. The lowest was 0.78. And the median was 5.84.
AGL's PB Ratio is ranked worse than 93.78% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs AGL: 9.88
During the past 12 months, Agilon Health's average Book Value Per Share Growth Rate was -63.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -50.50% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Agilon Health was -25.20% per year. The lowest was -50.50% per year. And the median was -37.85% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Agilon Health PB Ratio Related Terms
Agilon Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Agilon Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Agilon Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Agilon Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Agilon Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Agilon Health (AGL) has a PB Ratio of 9.88 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Agilon Health and its competitors. This is 69% above median its historical median of 5.84. Over the past decade, Agilon Health's PB Ratio has ranged from 0.78 to 13.13. According to the industry distribution chart, Agilon Health ranks #573 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 93.8%.
Is Agilon Health's PB Ratio too high?
Agilon Health's current PB Ratio of 9.88 is 69% above median its 10-year median of 5.84. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 13.13. The Healthcare Providers & Services industry median PB Ratio is 1.98. Agilon Health's value of 9.88 is 399% above this industry median. Based on the distribution chart, Agilon Health ranks #573 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's PB Ratio compare to AVAH and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #573 out of 611 companies for PB Ratio. This places Agilon Health in the lower half of its industry. The industry median PB Ratio is 1.98. Agilon Health's value of 9.88 is 399% above this benchmark. Historically, Agilon Health's own PB Ratio has ranged from 0.78 to 13.13 over the past decade. While the company's 10-year median is 5.84 vs. the industry median of 1.98, Agilon Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current PB Ratio of 9.88 is 399% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current PB Ratio is 9.88, which is 69% above median its own 10-year median of 5.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $107.99 — trading 14.3% above its estimated fair value. The current PB Ratio is 9.88, which is 69% above median its 10-year median of 5.84 and 399% above the Healthcare Providers & Services industry median of 1.98. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Agilon Health (AGL), the current PB Ratio is 9.88 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $107.99 is trading 14.3% above its estimated GF Value™ of $94.48.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
PB Ratio: 9.88 (69% above median its 10-year median of 5.84)
GF Value™: $94.48 vs. price of $107.99 (14.3% above fair value)
Industry Position: 399% above the Healthcare Providers & Services median (#573 of 611)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score
Get the complete analysis for AGL
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
